NO20055026L - Indolonacetamid-derivater, fremgangsmate for fremstilling og anvendelse av disse - Google Patents
Indolonacetamid-derivater, fremgangsmate for fremstilling og anvendelse av disseInfo
- Publication number
- NO20055026L NO20055026L NO20055026A NO20055026A NO20055026L NO 20055026 L NO20055026 L NO 20055026L NO 20055026 A NO20055026 A NO 20055026A NO 20055026 A NO20055026 A NO 20055026A NO 20055026 L NO20055026 L NO 20055026L
- Authority
- NO
- Norway
- Prior art keywords
- indolone
- processes
- preparation
- acetamide derivatives
- acetamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03007214 | 2003-03-31 | ||
PCT/EP2004/002691 WO2004087658A1 (en) | 2003-03-31 | 2004-03-16 | Indolone-acetamide derivatives, processes for preparing them and their uses |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20055026D0 NO20055026D0 (no) | 2005-10-28 |
NO20055026L true NO20055026L (no) | 2005-12-22 |
Family
ID=33104041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055026A NO20055026L (no) | 2003-03-31 | 2005-10-28 | Indolonacetamid-derivater, fremgangsmate for fremstilling og anvendelse av disse |
Country Status (19)
Country | Link |
---|---|
US (2) | US7645887B2 (de) |
EP (1) | EP1620399B1 (de) |
JP (1) | JP2006522041A (de) |
KR (1) | KR20050119186A (de) |
CN (1) | CN100364973C (de) |
AR (1) | AR043959A1 (de) |
AT (1) | ATE482193T1 (de) |
AU (1) | AU2004226288A1 (de) |
BR (1) | BRPI0408863A (de) |
CA (1) | CA2520568A1 (de) |
DE (1) | DE602004029245D1 (de) |
ES (1) | ES2353461T3 (de) |
HK (1) | HK1089768A1 (de) |
MX (1) | MXPA05009089A (de) |
NO (1) | NO20055026L (de) |
RU (1) | RU2005131317A (de) |
TW (1) | TW200508197A (de) |
WO (1) | WO2004087658A1 (de) |
ZA (1) | ZA200507231B (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200508197A (en) | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
CN1922141A (zh) * | 2004-02-23 | 2007-02-28 | 大日本住友制药株式会社 | 新的杂环化合物 |
ES2353394T3 (es) | 2004-07-22 | 2011-03-01 | Ucb Pharma, S.A. | Derivados de indolona, procedimientos para prepararlos y sus usos. |
WO2006118265A1 (ja) | 2005-04-28 | 2006-11-09 | Eisai R & D Management Co., Ltd. | 抗痴呆薬を含有する組成物 |
EP1912966A2 (de) * | 2005-06-01 | 2008-04-23 | Ucb, S.A. | 2-oxo-1-pyrrolidinderivate und ihren therapeutische verwendung fuer das zentralnervensystem |
US7790726B2 (en) * | 2005-08-16 | 2010-09-07 | Chemocentryx, Inc. | Monocyclic and bicyclic compounds and methods of use |
AR059265A1 (es) | 2006-02-07 | 2008-03-19 | Astrazeneca Ab | Compuestos espiro condensados con actividad inhibitoria en el receptor vaniloide1 (vr1) |
EP2010493B1 (de) | 2006-04-12 | 2016-01-27 | Merck Sharp & Dohme Corp. | Calciumkanal-antagonisten vom typ pyridylamid t |
WO2008133933A1 (en) * | 2007-04-26 | 2008-11-06 | Trustees Of Columbia University In The City Of New York | Methods, systems, and compositions for treating or ameliorating the effects of a non-congenital hypertonia |
EP2152262A2 (de) * | 2007-04-27 | 2010-02-17 | UCB Pharma, S.A. | Neue heterocyclische derivate zur behandlung von zns-erkrankungen |
AU2008317353B2 (en) * | 2007-10-24 | 2014-08-07 | Merck Sharp & Dohme Llc | Heterocycle phenyl amide T-type calcium channel antagonists |
JP2011500808A (ja) * | 2007-10-24 | 2011-01-06 | メルク・シャープ・エンド・ドーム・コーポレイション | 複素環アミドt型カルシウムチャネルアンタゴニスト |
CN107243007A (zh) | 2008-10-16 | 2017-10-13 | 约翰斯.霍普金斯大学 | 改善认知功能的方法和组合物 |
CA2789014C (en) | 2010-02-09 | 2019-01-15 | Michela Gallagher | Methods and compositions for improving cognitive function |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
MX2016009471A (es) | 2014-01-21 | 2016-10-13 | Janssen Pharmaceutica Nv | Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso. |
HUE045610T2 (hu) | 2014-01-21 | 2020-01-28 | Janssen Pharmaceutica Nv | 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk |
CN107540597A (zh) * | 2017-09-22 | 2018-01-05 | 苏州大学 | N‑乙酰二甲胺基吲哚‑2‑酮衍生物的制备方法 |
WO2019232083A1 (en) * | 2018-05-29 | 2019-12-05 | New York University | Compounds and methods for treating bacterial infections |
KR102669101B1 (ko) * | 2021-08-10 | 2024-05-27 | 충북대학교 산학협력단 | 신규한 옥소인돌린 기반 아세토히드라지드 및 이를 유효성분으로 포함하는 항암제 조성물 |
CN114874127B (zh) * | 2022-05-23 | 2023-06-09 | 中国药科大学 | 一种二氟羰基化吲哚酮类化合物的制备方法 |
WO2024039886A1 (en) | 2022-08-19 | 2024-02-22 | Agenebio, Inc. | Benzazepine derivatives, compositions, and methods for treating cognitive impairment |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3064910D1 (en) | 1979-06-12 | 1983-10-27 | Fujisawa Pharmaceutical Co | 2-oxo-benzothiazoline, benzoxazoline or indoline derivatives, their preparation, and pharmaceutical compositions comprising such derivatives |
JPS5697268A (en) * | 1979-12-28 | 1981-08-05 | Fujisawa Pharmaceut Co Ltd | Lower alkanoic acid derivative, salt and preparation thereof and preventing agent and remedy for diabetic complication containing the same as active constituent |
SU841264A1 (ru) * | 1980-02-20 | 1995-11-10 | Научно-исследовательский институт фармакологии АМН СССР | Амид-2-оксо-1-индолинуксусной кислоты, обладающий противосудорожной активностью |
DE3413572A1 (de) * | 1984-04-11 | 1985-10-24 | Hoechst Ag, 6230 Frankfurt | Oxindol-verbindungen zur behandlung der epilepsie |
GB8601160D0 (en) * | 1986-01-17 | 1986-02-19 | Fujisawa Pharmaceutical Co | Heterocyclic compounds |
DK288287A (da) * | 1986-06-09 | 1987-12-10 | Pfizer | Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande |
JPH0195766A (ja) | 1987-10-08 | 1989-04-13 | Tamanoisu Kk | 無蒸煮アルコール醪からの食酢の製造法 |
US5021576A (en) * | 1989-10-27 | 1991-06-04 | American Home Products Corporation | 2-Anilino phenylacetic acid derivatives |
CA2036307C (en) | 1990-03-08 | 2002-07-09 | Susan Jean Ward | 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method |
IE914003A1 (en) * | 1990-11-20 | 1992-05-20 | Astra Pharma Prod | Biologically Active Amines |
BR9200951A (pt) * | 1991-03-21 | 1992-11-17 | Hoffmann La Roche | Compostos, processo para sua producao,preparacoes farmaceuticas e uso |
US5322950A (en) * | 1991-12-05 | 1994-06-21 | Warner-Lambert Company | Imidazole with angiotensin II antagonist properties |
US5514690A (en) | 1992-11-17 | 1996-05-07 | E. R. Squibb & Sons, Inc. | Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline |
SE9302080D0 (sv) * | 1993-06-16 | 1993-06-16 | Ab Astra | New compounds |
JPH07304736A (ja) * | 1994-05-10 | 1995-11-21 | Kyowa Hakko Kogyo Co Ltd | インドール誘導体 |
US5565483A (en) * | 1995-06-07 | 1996-10-15 | Bristol-Myers Squibb Company | 3-substituted oxindole derivatives as potassium channel modulators |
FR2738818B1 (fr) * | 1995-09-18 | 1997-12-05 | Valentonine | Nouveaux derives d'oxydation d'indolylalkylamines, et leur utilisation a titre de medicament |
AU3645697A (en) * | 1996-07-08 | 1998-02-02 | Du Pont Pharmaceuticals Company | Amidinoindoles, amidinoazoles, and analogs thereof as inhibitors of factor xa and of thrombin |
JPH1095766A (ja) * | 1996-09-19 | 1998-04-14 | Sanwa Kagaku Kenkyusho Co Ltd | アセトアミド誘導体、及びその用途 |
CA2308994A1 (en) | 2000-05-19 | 2001-11-19 | Aegera Therapeutics Inc. | Neuroprotective compounds |
US7129250B2 (en) * | 2000-05-19 | 2006-10-31 | Aegera Therapeutics Inc. | Neuroprotective and anti-proliferative compounds |
US20020045566A1 (en) * | 2000-10-13 | 2002-04-18 | Gribkoff Valentin K. | Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
CA2519475A1 (en) * | 2003-03-14 | 2004-09-30 | Merck & Co., Inc. | Bicyclic anilide spirohydantoin cgrp receptor antagonists |
TW200508197A (en) | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
ES2353394T3 (es) * | 2004-07-22 | 2011-03-01 | Ucb Pharma, S.A. | Derivados de indolona, procedimientos para prepararlos y sus usos. |
-
2004
- 2004-03-15 TW TW093106822A patent/TW200508197A/zh unknown
- 2004-03-16 DE DE602004029245T patent/DE602004029245D1/de not_active Expired - Lifetime
- 2004-03-16 AU AU2004226288A patent/AU2004226288A1/en not_active Abandoned
- 2004-03-16 CN CNB2004800087283A patent/CN100364973C/zh not_active Expired - Fee Related
- 2004-03-16 US US10/550,667 patent/US7645887B2/en not_active Expired - Fee Related
- 2004-03-16 ZA ZA200507231A patent/ZA200507231B/en unknown
- 2004-03-16 CA CA002520568A patent/CA2520568A1/en not_active Abandoned
- 2004-03-16 WO PCT/EP2004/002691 patent/WO2004087658A1/en active Application Filing
- 2004-03-16 ES ES04720863T patent/ES2353461T3/es not_active Expired - Lifetime
- 2004-03-16 KR KR1020057018789A patent/KR20050119186A/ko not_active Application Discontinuation
- 2004-03-16 EP EP04720863A patent/EP1620399B1/de not_active Expired - Lifetime
- 2004-03-16 RU RU2005131317/04A patent/RU2005131317A/ru not_active Application Discontinuation
- 2004-03-16 BR BRPI0408863-8A patent/BRPI0408863A/pt not_active IP Right Cessation
- 2004-03-16 JP JP2006504696A patent/JP2006522041A/ja active Pending
- 2004-03-16 MX MXPA05009089A patent/MXPA05009089A/es not_active Application Discontinuation
- 2004-03-16 AT AT04720863T patent/ATE482193T1/de not_active IP Right Cessation
- 2004-03-30 AR ARP040101049A patent/AR043959A1/es not_active Application Discontinuation
-
2005
- 2005-10-28 NO NO20055026A patent/NO20055026L/no not_active Application Discontinuation
-
2006
- 2006-09-15 HK HK06110230A patent/HK1089768A1/xx not_active IP Right Cessation
-
2009
- 2009-11-20 US US12/622,533 patent/US7964593B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BRPI0408863A (pt) | 2006-04-11 |
EP1620399A1 (de) | 2006-02-01 |
US20070043038A1 (en) | 2007-02-22 |
EP1620399B1 (de) | 2010-09-22 |
RU2005131317A (ru) | 2006-02-27 |
CN1768036A (zh) | 2006-05-03 |
US7964593B2 (en) | 2011-06-21 |
AR043959A1 (es) | 2005-08-17 |
HK1089768A1 (en) | 2006-12-08 |
KR20050119186A (ko) | 2005-12-20 |
US20100069375A1 (en) | 2010-03-18 |
MXPA05009089A (es) | 2005-11-17 |
AU2004226288A1 (en) | 2004-10-14 |
ZA200507231B (en) | 2006-11-29 |
DE602004029245D1 (de) | 2010-11-04 |
NO20055026D0 (no) | 2005-10-28 |
WO2004087658A1 (en) | 2004-10-14 |
US7645887B2 (en) | 2010-01-12 |
JP2006522041A (ja) | 2006-09-28 |
ATE482193T1 (de) | 2010-10-15 |
CN100364973C (zh) | 2008-01-30 |
CA2520568A1 (en) | 2004-10-14 |
ES2353461T3 (es) | 2011-03-02 |
TW200508197A (en) | 2005-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055026L (no) | Indolonacetamid-derivater, fremgangsmate for fremstilling og anvendelse av disse | |
MY142329A (en) | Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents. | |
NO20076413L (no) | Multisykliske forbindelser og fremgangsmater for deres anvendelse | |
MY153424A (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
TW200612905A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
MY147767A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
TW200730515A (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
NO20050525L (no) | Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer | |
ATE313532T1 (de) | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen | |
WO2007095050A3 (en) | N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase | |
DE602004014361D1 (de) | Verwendung von oxazolidinon-chinolin-hybrid-antibiotika zur behandlung von anthrax und anderen infektionen | |
SE0301700D0 (sv) | Novel compounds | |
EA201170571A1 (ru) | Способы и композиции для улучшения когнитивной функции | |
ATE449604T1 (de) | Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
HK1085140A1 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
DK1789398T3 (da) | 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE) | |
HUP0302384A2 (hu) | Sejtek bioenergia metabolizmusában szerepet játszó biokémiai vegyületeket tartalmazó készítmények és alkalmazásuk | |
ATE482194T1 (de) | Indolonderivate, verfahren zu deren herstellung und deren anwendungen | |
MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
IL171974A0 (en) | Tetrahydrocarbazole derivatives and their pharmaceutical use | |
DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
NO20060535L (no) | Aztreonam-L-lysin og fremgangsmater for fremstilling av dette | |
ATE424823T1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate als arzneimittel zur behandlung von unfruchtbarkeit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |